SCHEMBL14508324

SCHEMBL14508324

CC1(C)c2cc(-c3cccc(Br)c3)ccc2-c2ccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5cccc(Br)c5)ccc3-4)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.50
TDP2 O95551 1/20 0.49
GABRG2 P18507 4/20 0.40
GABRB3 P28472 4/20 0.40
GABRA5 P31644 4/20 0.40
GABRA3 P34903 4/20 0.40
GABRA1 P14867 3/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 3/20 0.39
IDO1 P14902 1/20 0.39
METAP2 P50579 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10042455 0.93 PGR (0.46) PGRTDP2GABRG2GABRB3GABRA5
SCHEMBL29789015 0.93 PGR (0.46) PGRTDP2GABRG2GABRB3GABRA5
SCHEMBL17752306 0.92 PGR (0.45) PGRTDP2GABRG2GABRB3GABRA5
SCHEMBL1649907 0.86 PDK2 (0.40) PGRTDP2RAB9ANPC1SMN1; SMN2
SCHEMBL1648023 0.86 PDK2 (0.40) PGRTDP2RAB9ANPC1SMN1; SMN2
SCHEMBL14508381 0.86 PDK2 (0.40) PGRTDP2RAB9ANPC1SMN1; SMN2
SCHEMBL16366151 0.86 MAPK1 (0.47) PGRTDP2RAB9ANPC1MEN1
SCHEMBL429037 0.86 MAPK1 (0.47) PGRTDP2RAB9ANPC1MEN1
SCHEMBL431820 0.86 MAPK1 (0.47) PGRTDP2RAB9ANPC1MEN1
SCHEMBL29895759 0.86 MAPK1 (0.47) PGRTDP2RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 PGR 756/4885TDP2 4014/4885GABRG2 3624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.